SEC Form 4 · accession 0001628280-26-058008
Arcutis Biotherapeutics, Inc. · ARQT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Howard G. Welgus
Director
Period of report
Aug 17, 2026
Accepted (ET)
Aug 19, 2026 · 4:57 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001787306
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2026 | M | 822 | $6.5223 | A | 37,931 | D | |
| Common Stock | Aug 17, 2026 | M | 1,019 | $7.51 | A | 38,950 | D | |
| Common Stock | Aug 17, 2026 | M | 2,255 | $8.63 | A | 41,205 | D | |
| Common StockF2 | Aug 17, 2026 | S | 4,730 | $26.1807 | D | 36,475 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $6.5223 | Aug 17, 2026 | M | 822 | D | — | Nov 20, 2029 | Common Stock | 822 | 7,396 | D |
| Stock Option (right to buy)F3 | $7.51 | Aug 17, 2026 | M | 1,019 | D | — | May 31, 2033 | Common Stock | 1,019 | 9,163 | D |
| Stock Option (right to buy)F3 | $8.63 | Aug 17, 2026 | M | 2,255 | D | — | Jun 14, 2034 | Common Stock | 2,255 | 20,287 | D |
Explanation of responses
- F1The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027.
- F2The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $26.10 to $26.25 inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F3The option is fully vested.